Varex/$VREX
1D1W1MYTD1Y5YMAX
Capital at risk
About Varex
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
- Ticker
- $VREX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 2,500
- Headquarters
- Salt Lake City, United States
- Website
- www.vareximaging.com
Varex Metrics
BasicAdvanced
$778M
35.50
$0.52
0.88
-
Price and volume
Market cap
$778M
Beta
0.88
52-week high
$18.63
52-week low
$9.09
Average daily volume
1.3M
Financial strength
Current ratio
3.378
Quick ratio
1.306
Long term debt to equity
0.698
Total debt to equity
0.743
Interest coverage (TTM)
1.86%
Profitability
EBITDA (TTM)
94.4
Gross margin (TTM)
34.32%
Net profit margin (TTM)
2.55%
Operating margin (TTM)
7.76%
Effective tax rate (TTM)
18.77%
Revenue per employee (TTM)
$350,000
Management effectiveness
Return on assets (TTM)
3.86%
Return on equity (TTM)
4.59%
Valuation
Price to earnings (TTM)
35.502
Price to revenue (TTM)
0.895
Price to book
1.57
Price to tangible book (TTM)
2.71
Price to free cash flow (TTM)
-38.314
Free cash flow yield (TTM)
-2.61%
Free cash flow per share (TTM)
-0.482
Growth
Revenue change (TTM)
5.31%
Earnings per share change (TTM)
-116.00%
3-year revenue growth (CAGR)
-1.22%
10-year revenue growth (CAGR)
3.59%
3-year earnings per share growth (CAGR)
-10.46%
10-year earnings per share growth (CAGR)
-10.94%
What the Analysts think about Varex
Analyst ratings (Buy, Hold, Sell) for Varex stock.
Analyst projections of the future price of Varex stock.
Bulls say / Bears say
Teledyne has agreed to acquire Varex Imaging for $18.90 per share in cash, valuing the transaction at approximately $1.1 billion and representing a significant premium over recent trading levels (Teledyne)
Varex’s Industrial segment revenue grew 26% year-over-year to $77 million in Q3 FY26, driven by robust demand for cargo and vehicle inspection systems (SEC)
The company generated $21 million of operating cash flow in Q3 FY26, bolstered by $17 million in IEEPA tariff refunds, improving liquidity ahead of the merger close (SEC)
Medical segment revenue fell 6% year-over-year to $134 million in Q3 FY26, signaling softness in its core healthcare imaging business (SEC)
The pending merger is subject to regulatory and shareholder approvals and includes termination rights, posing execution and integration risks that could jeopardize deal completion (Teledyne)
Cash and equivalents declined to $99 million at Q3-end from $155 million at the end of fiscal 2025, narrowing liquidity as working capital needs rise (SEC)
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2026.
Varex Financial Performance
Revenues and expenses
Varex Earnings Performance
Company profitability
Upcoming events
No upcoming events
Varex News
AllArticlesVideos

VREX Stock Alert: Halper Sadeh LLC is Investigating Whether Varex Imaging Corporation is Obtaining a Fair Price for its Shareholders
Business Wire3 days ago

Varex Imaging Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Varex Imaging Corporation - VREX
Business Wire1 month ago

Teledyne Technologies to Buy Varex Imaging for $1.1 Billion
WSJ1 month ago
Funds containing Varex
Fund name | Fund size | $VREX weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.